Dr. Markus Zehe

Publikationen

“Combined In-Solution Fragment Screening and Crystallographic Binding-Mode Analysis with a Two-Domain Hsp70 Construct.”
M. Zehe, J. Kehrein, C. Schollmayer, C. Plank, H. Kovacs, E. Merino Asumendi, U. Holzgrabe, C. Grimm and C. Sotriffer
ACS Chem. Biol. 19 (2) (2024) 392–406
DOI: 10.1021/acschembio.3c00589

“Characterization of binding properties of ephedrine derivatives to human alpha-1-acid glycoprotein”
S. Schmidt, M. Zehe and U. Holzgrabe
Eur. J. Pharm. Sci. 181 (1) (2023) 106333
DOI: 10.1016/j.ejps.2022.106333

“Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97”
S. Bothe, P. Hänzelmann, S. Böhler, J. Kehrein, M. Zehe, C. Wiedemann, U. A. Hellmich, R. Brenk, H. Schindelin and C. Sotriffer
Commun. Chem. 5 (1) (2022) 169
DOI: 10.1038/s42004-022-00782-5

“Sesquiterpenes and sesquiterpenoids harbor modulatory allosteric potential and affect inhibitory GABAA receptor function in vitro.”
D. Janzen, B. Slavik, M. Zehe, C. Sotriffer, H. M. Loos, A. Buettner and C. Villmann
J. Neurochem. 159 (2021) 101-115
DOI: 10.1111/jnc.15469

"Investigation of orally delivered carbon monoxide for postoperative ileus"
J. Van Dingenen, C. Steiger, M. Zehe, L. Meinel, R. A. Lefebvre
Eur. J. Pharm. Biopharm. 130 (2018) 306-313
DOI: 10.1016/j.ejpb.2018.07.009

"Controlled therapeutic gas delivery systems for quality-improved transplants"
C. Steiger, J. Wollborn, M. Gutmann, M. Zehe, C. Wunder, L. Meinel
Eur. J. Pharm. Biopharm. 97 A (2015) 96-106
DOI: 10.1016/j.ejpb.2015.10.009